Author

Fatwa Adikusuma

Observed names: Adikusuma, Fatwa, Fatwa L Adikusuma

Institutions: South Australian Health and Medical Research Institute, Adelaide University, The University of Adelaide

Observed institutions: Diponegoro University, Commonwealth Scientific and Industrial Research Organisation, South Australian Health and Medical Research Institute, Adelaide University, SA Genome Editing Facility, The University of Adelaide

ORCID: 0000-0003-2163-0514

Observed ORCID: 0000-0003-2163-0514

OpenAlex ID: A5069776169

Large deletions induced by Cas9 cleavage

2018 · Fatwa Adikusuma, Sandra Piltz, et al. · Nature · 375

PDF

Viperin is an important host restriction factor in control of Zika virus infection

2017 · Kylie H. Van der Hoek, Nicholas S. Eyre, et al. · Scientific Reports · 114

PDF

Targeted Deletion of an Entire Chromosome Using CRISPR/Cas9

2017 · Fatwa Adikusuma, Nicole Williams, et al. · Molecular Therapy · 102

PDF

Optimized nickase- and nuclease-based prime editing in human and mouse cells

2021 · Fatwa Adikusuma, Caleb Lushington, et al. · Nucleic Acids Research · 91

PDF

Antisense oligonucleotide therapy for KCNT1 encephalopathy

2022 · Lisseth Estefania Burbano, Melody Li, et al. · JCI Insight · 83

Versatile single-step-assembly CRISPR/Cas9 vectors for dual gRNA expression

2017 · Fatwa Adikusuma, Chandran Pfitzner, et al. · PLoS ONE · 60

PDF

A Y-chromosome shredding gene drive for controlling pest vertebrate populations

2019 · Thomas AA Prowse, Fatwa Adikusuma, et al. · eLife · 51

Progress Toward Zygotic and Germline Gene Drives in Mice

2020 · Chandran Pfitzner, Melissa A. White, et al. · The CRISPR Journal · 45

PDF

Functional Equivalence of the SOX2 and SOX3 Transcription Factors in the Developing Mouse Brain and Testes

2017 · Fatwa Adikusuma, Daniel Pederick, et al. · Genetics · 31

CRISPR applications for Duchenne muscular dystrophy: From animal models to potential therapies

2022 · Yu C. J. Chey, Jayshen Arudkumar, et al. · WIREs Mechanisms of Disease · 25

PDF

Optimal SpCas9- and SaCas9-mediated gene editing by enhancing gRNA transcript levels through scaffold poly-T tract reduction

2025 · Yu C. J. Chey, Luke Gierus, et al. · BMC Genomics · 16

PDF

Expanding the RNA-Guided Endonuclease Toolkit for Mouse Genome Editing

2018 · Louise Robertson, Daniel Pederick, et al. · The CRISPR Journal · 9

Genetically edited human placental organoids cast new light on the role of ACE2

2025 · Anya L. Arthurs, Bianca Dietrich, et al. · Cell Death and Disease · 7

PDF

CRISPR-mediated megabase-scale transgene de-duplication to generate a functional single-copy full-length humanized DMD mouse model

2024 · Yu C. J. Chey, Mark Corbett, et al. · BMC Biology · 7

PDF

A primer on prime: A prime editing update from advances to first-in-human trial

2026 · Caleb Lushington, Paul Thomas, et al. · Molecular Therapy · 6

The Nestin neural enhancer is essential for normal levels of endogenous Nestin in neuroprogenitors but is not required for embryo development

2021 · Ella Thomson, Ruby Dawson, et al. · PLoS ONE · 4

PDF

CRISPR-mediated generation and comprehensive phenotyping of Duchenne Muscular Dystrophy mouse models

2024 · Jayshen Arudkumar, Yu Chinn Joshua Chey, et al. · BMC Methods · 3

In vitro Transcription (IVT) of Guide RNAs for Cytoplasmic Microinjection v1

2024 · Jayshen Arudkumar, Yu Chinn Joshua Chey, et al. · 1

PDF

Author response: A Y-chromosome shredding gene drive for controlling pest vertebrate populations

2019 · Thomas AA Prowse, Fatwa Adikusuma, et al. · eLife · 1

Engineered trophoblast organoids recapitulate molecular and functional features of preeclampsia

2026 · Anya L Arthurs, Caleb Lushington, et al. · bioRxiv (Cold Spring Harbor Laboratory)

PDF

Genomic DNA Extraction and Genotyping PCR on Mouse Tissues v1